Skip to main content
. Author manuscript; available in PMC: 2016 Jul 22.
Published in final edited form as: Med Oncol. 2016 Jan 9;33(2):13. doi: 10.1007/s12032-015-0728-2

Figure 2. TFFS for Patient Subsets.

Figure 2

Kaplan-Meier Analysis of Treatment Failure-Free Survival (TFFS) for Patients Treated with Nab-Paclitaxel for Recurrent or Platinum-Refractory Stage IV Non-Small Cell Lung Cancer (NSCLC) Based on A. Prior Taxane Exposure (N = No prior Taxane, Y = Prior Taxane); B. Line of Therapy; and C. Histology (AdenoCA = Pure Adenocarcinoma Histology)